Related Experiment Video
Updated: May 18, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Changes in the safety paradigm with percutaneous coronary interventions in the modern era: Lessons learned from the
Alfredo E Rodríguez1, Carlos Fernández-Pereira, Alfredo M Rodríguez-Granillo
1Alfredo E Rodríguez, Carlos Fernández-Pereira, Alfredo M Rodríguez-Granillo, Cardiovascular Research Center, Cardiac Unit Otamendi Hospital, Azcuenga 870, 1072 Buenos Aires, Argentina.
Insights
Coronary artery bypass surgery (CABG) shows improved survival over percutaneous coronary interventions (PCI) with drug-eluting stents, especially in older patients. Previous studies found similar outcomes, but recent data suggests CABG is superior for complex coronary artery disease.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Cardiac Surgery
Background:
- Past comparative trials of percutaneous coronary interventions (PCI) with balloon angioplasty or bare metal stents (BMS) versus coronary artery bypass surgery (CABG) showed similar long-term survival.
- Meta-analyses indicated no survival differences, though CABG offered advantages for diabetic and elderly patients.
- Extent of coronary artery disease (CAD) did not predict poor outcomes with PCI before drug-eluting stents (DES).
Purpose of the Study:
- To evaluate recent findings on revascularization strategies for coronary artery disease (CAD).
- To investigate the comparative effectiveness of PCI with DES versus CABG, particularly in elderly patients.
- To explore reasons for observed outcome differences and potential solutions.
Main Methods:
- Review of past comparative effectiveness trials and meta-analyses.
- Analysis of the ASCERT registry data comparing PCI with DES versus CABG.
- Examination of other registries and randomized trials reporting similar outcomes.
Main Results:
- Recent ASCERT registry data shows higher mortality with PCI in patients ≥ 65 years compared to CABG, even in low-risk subgroups.
- PCI, utilizing early DES designs in 78% of cases, demonstrated a lack of clinical benefit and higher mortality across various patient groups.
- Findings are supported by other registries and trials, despite the ASCERT registry not being randomized.
Conclusions:
- Recent evidence suggests CABG may offer superior survival compared to PCI with DES, particularly in older populations.
- The clinical benefit of early DES implantation appears limited, challenging previous assumptions about PCI effectiveness.
- Further research is needed to understand these outcomes and identify optimal revascularization strategies.
Abstract:
In the past, comparative effectiveness trials evaluating percutaneous coronary interventions (PCI), using either balloon angioplasty or bare metal stent (BMS) implantation, versus coronary artery bypass surgery (CABG) found similar survival rates at long-term follow-up with both revascularization strategies. Two major meta-analyses of these trials reported 5- and 6-year comparative effectiveness between PCI and CABG: one included only four trials that compared PCI with BMS implantation versus CABG whereas the largest one also included trials using balloon angioplasty. In these studies, the authors observed no survival differences between groups although a significant survival advantage was seen in diabetics treated with CABG and this benefit was also perceived in elderly patients. In both reports, number of involved vessels, presence of left anterior descending artery stenosis or poor left ventricular ejection fraction were no predictors of poor survival with PCI. Therefore, extent of the coronary artery disease (CAD) was not associated with poor outcome after PCI in the pre-drug eluting stent (DES) era. Recently, the ASCERT (Database Collaboration on the Comparative Effectiveness of Revascularization Strategies) registry found higher mortality rate with PCI in patients ≥ 65 years old in comparison with CABG, and advantages of surgery were seen in all subgroups including those at low risk. In this registry, PCI was accomplished by implantation of the first type of DES designs in 78% of cases. The intriguing observation of high mortality rate with PCI, including for non-diabetics and patients with two-vessel CAD, meaning a lack of clinical benefit with DES implantation, had not been seen previously. The study was not randomized, although its results are largely strengthened by its sample size. In this manuscript, the authors describe other registries and randomized trials reporting similar results supporting the findings of the aforementioned study and explore the reasons for these results, while also searching for potential solutions.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Cardiac Catheterization III: Left Heart Catheterization
